Jeff Malet/Newscom via ZUMA

Fight disinformation: Sign up for the free Mother Jones Daily newsletter and follow the news that matters.

Atrios attracts my attention today with this headline:

Look Like You’re Doing Something
But don’t actually do anything.

The link is to an Alex Pareene piece about a prescription drug plan that’s supported by Nancy Pelosi. The plan is pretty simple: the HHS secretary would be required to negotiate lower prices for at least 25 prescription drugs each year. If a negotiation is unsuccessful, the GAO would be allowed to set a price close to the typical amount charged for the drug in other countries. Here’s Pareene:

Do Democrats Actually Want to Make Drugs Cheaper?
Or are they just looking to cut a deal for the sake of cutting a deal?

….The basic, blinding flaw in this proposal is to task Donald Trump’s health and human services secretary, a former pharmaceutical industry executive and lobbyist, with deciding, at his personal discretion, to negotiate the prices of “at least” 25 drugs. But even without that bit of biographical detail, you can already figure out the various ways that a price intervention all but designed to function as anything but a serious curb on drug pricing can’t possibly work, right?

For one thing, America’s unique dilemma in need of remedy is “drug costs,” not “25 drugs’ costs.”…AARP’s Public Policy Institute last year tracked the retail prices of hundreds of brand-name drugs commonly prescribed to older Americans and found that more than 200 of them increased in price beyond the rate of inflation in 2017.

….We must again remind any readers given to policy transports driven by logic and sound political calculation that the current, non-hypothetical HHS secretary is a former pharmaceutical industry executive. We must also gingerly remind said readers that all available evidence from the last 40 or so years of hard-right governance in Washington shows that Republicans will always place industry profits above their constituents’ needs.

I adore Pareene’s Dorothy-Parkeresque poison pen, and I’m reluctant to run the risk of having it turned on me. It would probably seem a little less charming then. Still, I want to point out that Pelosi is likely a step ahead of him. Sure, this plan will accomplish nothing now, but how about in 2021, after President Warren nominates Michael Moore to be her HHS secretary? It would be handy to have a law already in place that allows—nay, requires—the negotiation of “at least” 25 drug prices. My guess is that this would be translated as “approximately all” and that Mr. Roger & Me would be delighted to allow negotiations to fail so that prices could default to a European level. This could be one of the greatest bills of all time!

Needless to say, there are at least one or two Republicans who can figure this out too, which means this plan has no chance of going anywhere. So why not support it and make Republicans look like the bad guys? What’s not to like?

WE CAME UP SHORT.

We just wrapped up a shorter-than-normal, urgent-as-ever fundraising drive and we came up about $45,000 short of our $300,000 goal.

That means we're going to have upwards of $350,000, maybe more, to raise in online donations between now and June 30, when our fiscal year ends and we have to get to break-even. And even though there's zero cushion to miss the mark, we won't be all that in your face about our fundraising again until June.

So we urgently need this specific ask, what you're reading right now, to start bringing in more donations than it ever has. The reality, for these next few months and next few years, is that we have to start finding ways to grow our online supporter base in a big way—and we're optimistic we can keep making real headway by being real with you about this.

Because the bottom line: Corporations and powerful people with deep pockets will never sustain the type of journalism Mother Jones exists to do. The only investors who won’t let independent, investigative journalism down are the people who actually care about its future—you.

And we hope you might consider pitching in before moving on to whatever it is you're about to do next. We really need to see if we'll be able to raise more with this real estate on a daily basis than we have been, so we're hoping to see a promising start.

payment methods

WE CAME UP SHORT.

We just wrapped up a shorter-than-normal, urgent-as-ever fundraising drive and we came up about $45,000 short of our $300,000 goal.

That means we're going to have upwards of $350,000, maybe more, to raise in online donations between now and June 30, when our fiscal year ends and we have to get to break-even. And even though there's zero cushion to miss the mark, we won't be all that in your face about our fundraising again until June.

So we urgently need this specific ask, what you're reading right now, to start bringing in more donations than it ever has. The reality, for these next few months and next few years, is that we have to start finding ways to grow our online supporter base in a big way—and we're optimistic we can keep making real headway by being real with you about this.

Because the bottom line: Corporations and powerful people with deep pockets will never sustain the type of journalism Mother Jones exists to do. The only investors who won’t let independent, investigative journalism down are the people who actually care about its future—you.

And we hope you might consider pitching in before moving on to whatever it is you're about to do next. We really need to see if we'll be able to raise more with this real estate on a daily basis than we have been, so we're hoping to see a promising start.

payment methods

We Recommend

Latest

Sign up for our free newsletter

Subscribe to the Mother Jones Daily to have our top stories delivered directly to your inbox.

Get our award-winning magazine

Save big on a full year of investigations, ideas, and insights.

Subscribe

Support our journalism

Help Mother Jones' reporters dig deep with a tax-deductible donation.

Donate